Journal article
Soluble CD14 and fracture risk
Osteoporosis international, Vol.27(5), pp.1755-1763
05/2016
DOI: 10.1007/s00198-015-3439-9
PMID: 26659065
Abstract
Soluble CD14 (sCD14) is an inflammatory marker associated with osteoclasts. Using Cox proportional hazards models, we found a positive association between plasma levels of sCD14 and risk of incident fracture among participants in the Cardiovascular Health Study. sCD14 may be useful in identifying those at risk for fracture.
Soluble CD14, a proinflammatory cytokine, is primarily derived from macrophages/monocytes that can differentiate into osteoclasts. The purpose of this study was to examine the relationship between sCD14 levels and osteoporotic fractures.
In the Cardiovascular Health Study, 5462 men and women had sCD14 levels measured at baseline. Incident hip fractures (median follow-up time 12.5 years) and incident composite fractures (defined as the first hip, pelvis, humerus, or distal radius fracture, median follow-up 8.6 years) were identified from hospital discharge summaries and/or Medicare claims data. Cox proportional hazards models were used to model the association between sCD14 levels and time to incident hip or composite fracture, overall and as a function of race and gender.
In unadjusted models, there was a positive association between sCD14 levels (per 1 standard deviation increase, i.e., 361.6 ng/mL) and incident hip (HR, 1.26; 95 % CI, 1.17, 1.36) and composite (HR, 1.20; 95 % CI, 1.12, 1.28) fractures. When models were fully adjusted for demographics, lifestyle factors, and medication use, these associations were no longer significant. However, in whites, the association of sCD14 levels with hip fractures remained significant in fully adjusted models (HR, 1.11; 95 % CI, 1.01-1.23). Associations of sCD14 levels with hip and composite fracture did not differ between men and women.
In this large cohort of community-dwelling older adults, higher sCD14 levels were associated with an increased risk of incident hip fractures in whites.
Details
- Title: Subtitle
- Soluble CD14 and fracture risk
- Creators
- M Bethel - Charlie Norwood VA Medical CenterP Bůžková - University of WashingtonH A Fink - University of Minnesota SystemJ A Robbins - University of California, DavisJ A Cauley - University of PittsburghJ Lee - University of California, DavisJ I Barzilay - Emory UniversityD I Jalal - University of Colorado Anschutz Medical CampusL D Carbone - Charlie Norwood VA Medical Center
- Resource Type
- Journal article
- Publication Details
- Osteoporosis international, Vol.27(5), pp.1755-1763
- DOI
- 10.1007/s00198-015-3439-9
- PMID
- 26659065
- ISSN
- 0937-941X
- eISSN
- 1433-2965
- Grant note
- N01HC85080 / NHLBI NIH HHS N01HC55222 / NHLBI NIH HHS N01HC85086 / NHLBI NIH HHS R01AG023629 / NIA NIH HHS N01HC85082 / NHLBI NIH HHS U01HL080295 / NHLBI NIH HHS HHSN268200800007C / PHS HHS N01HC85081 / NHLBI NIH HHS HHSN268201200036C / PHS HHS N01HC85083 / NHLBI NIH HHS N01HC85079 / NHLBI NIH HHS
- Language
- English
- Date published
- 05/2016
- Academic Unit
- Nephrology; Internal Medicine
- Record Identifier
- 9984359570102771
Metrics
12 Record Views